Conformational studies of vasopressin and mesotocin using NMR spectroscopy and molecular modelling methods. Part I: Studies in water

Journal of Peptide Science

Volumn 14, Issue 1, 2008, Pages 76-84

  Sikorska, Emilia ^a   Rodziewicz Motowidło, Sylwia ^a  

^a UNIVERSITY OF GDA SK   (Poland)

Author keywords

Arginine vasopressin (AVP); Mesotocin (MT); Molecular dynamics; NMR; Time averaged (TAV)

Indexed keywords

ARGIPRESSIN; CYSTEINE; MESOTOCIN; PROLINE; WATER;

AMINO ACID SEQUENCE; AQUEOUS SOLUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMICAL BOND; CIS TRANS ISOMERISM; CONFORMATIONAL TRANSITION; HORMONE STRUCTURE; MOLECULAR DYNAMICS; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS;

ANIMALS; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; OXYTOCIN; PEPTIDES; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; PROTONS; SOLVENTS; VASOPRESSINS; WATER;

AMPHIBIA; ANIMALIA; AVES; MACROPODIDAE; MAMMALIA; METATHERIA; PISCES;

EID: 38849110093     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.918     Document Type: Article

References (63)

1. Acher R, Chauvet J, Chauvet MT. Man and the chimaera. Selective versus neutral oxytocin evolution. Adv. Exp. Med. Biol. 1995; 395: 615-627.
2. van Kesteren RE. Smit AB, Dirks RW, De With ND, Geraerts WPM, Joosse J. Evolution of the vasopressin/oxytocin superfamily: characterization of a cDNA encoding a vasopressin-related precursor, preproconopressin, from the mollusc Lymnaea stagnalis. Proc. Natl. Acad. Sci. U.S.A. 1992; 89: 4593-4597.
3. Bockaert J, Roy C, Rajerison R, Jard S. Specific binding of (3H) lysine-vasopressin to pig kidney plasma membranes. Relationship of receptor occupancy to adenylate cyclase activation. J. Biol. Chem. 1973; 248: 5922-5931.
4. Luft FC, Steinberg H, Ganten U, Meyer D, Gless KH, Lang RE, Fineberg NS, Rascher W, Unger T, Ganten D. Effect of sodium chloride and sodium bicarbonate on blood pressure in stroke-prone spontaneously hypertensive rats. Clin. Sci. (London) 1988; 74: 577-585.
5. Versteeg CA. Bohus B, de Jong W. Attenuation by arginine- and desglycinamide-lysine-vasopressin of a centrally evoked pressor response. J. Auton. Nerv. Syst. 1982; 6: 253-262.
6. Jard S. Gaillard RC, Guillon G, Marie J, Schoenenberg P, Muller AF, Manning M, Sawyer WH. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol. Pharmocol. 1986; 30: 171-177.
7. Wilkinson MF, Kasting NW. The antipyretic effects of centrally administered vasopressin at different ambient temperatures. Brain Res. 1987; 415: 275-280.
8. Wang Z, Young LJ, De Vries GJ, Insel TR. Voles and vasopressin: a review of molecular. cellular, and behavioral studies of pair bonding and paternal behaviors. Prog. Brain Res. 1998; 119: 483-499.
9. Kendrick KM, Keverne EB, Baldwin BA. Intracerebroventricular oxytocin stimulates maternal behaviour in the sheep. Neuroendocrinology 1987; 46: 56-61.
10. Berkowitz BA, Sherman S. Characterization of vasopressin analgesia. J. Pharmacol. Exp. Ther. 1982; 220: 329-334.
11. van Ree JM, De Wied D. Effect of neurohypophyseal hormones on morphine dependence. Psychoneuroendocrinology 1977; 2: 35-41.
12. Barberis C, Tribollet E. The vasopressin and oxytocin receptors in the central nervous system. Crit. Rev. Neurobiol. 1996; 10: 119-154.
13. Siebel AL, Gehring HM, Nave CD, Bathgate RAD, Borchers CE, Parry LJ. Up-regulation of mesotocin receptors in the tammar wallaby myometrium is pregnancy-specific and independent of estrogen. Biol. Reprod. 2002; 66: 1237-1243.
14. Parry LJ, Bathgate RA. Mesotocin receptor gene and protein expression in the prostate gland, but not testis, of the tammar wallaby. Macropus eugenii. Biol. Reprod. 1998; 59: 1101-1107.
15. Shakhmatova EI, Prutskova NP. The role of mesotocin in the regulation of osmotic permeability of the urinary bladder epithelium in the frog. Ross. Fiziol. Zh. Im. I.M. Sechenova 1998; 84: 238-243.
16. Robinzon B, Koike TI, Marks PA. Oxytocin antagonist blocks the vasodepressor but not the vasopressor effect of neurohypophysial peptides in chickens. Peptides 1994; 15: 1407-1413.
17. Le Mevel JC, Pamantung TF, Mabin D, Vaudry H. Effects of central and peripheral administration of arginine vasotocin and related neuropeptides on blood pressure and heart rate in the conscious trout. Brain Res. 1993; 610: 82-89.
18. Kohno S, Kamishima Y, Iguchi T. Molecular cloning of an anuran V(2) type [Arg(8)] vasotocin receptor and mesotocin receptor: functional characterization and tissue expression in the Japanese tree frog (Hyla japonica). Gen. Comp. Endocrinol. 2003; 132: 485-498.
19. Liwo A, Tempczyk A, O3dziej S, Shenderovich MD, Hruby VJ, Talluri S, Ciarkowski J, Kasprzykowski F, Łankiewicz L, Grzonka Z. Exploration of the conformational space of oxytocin and arginine-vasopressin using the electrostatically driven Monte Carlo and molecular dynamics methods. Biopolymers 1996; 38: 157-175.
20. Schmidt JM, Ohlenschläger O, Rüterjans H, Grzonka Z, Kojro E, Pavo I, Fahrenholz F. Conformation of [8-arginine]vasopressin and V1 antagonists in dimethyl sulfoxide solution derived from two-dimensional NMR spectroscopy and molecular dynamics simulation. Eur. J. Biochem. 1991; 201: 355-371.
21. Iwadate M, Nagao E, Williamson MP, Ueki M, Asakura T. Structure determination of [Arg8] vasopressin methylenedithioether in dimethylsulfoxide using NMR. Eur. J. Biochem. 2000; 267: 4504-4510.
22. Walse B, Kihlberg J, Drakenberg T. Conformation of desmopressin, an analogue of the peptide hormone vasopressin, in aqueous solution as determined by NMR spectroscopy. Eur. J. Biochem. 1998; 252: 428-440.
23. Wang J, Hodges RS, Sykes BD. Effect of trifluoroethanol on the solution structure and flexibility of desmopressin: a two-dimensional NMR study. Int. J. Pept. Protein Res. 1995; 45: 471-481.
24. Langs DA, Smith GD, Stezowski JJ, Hughes RE. Structure of pressinoic acid: the cyclic moiety of vasopressin. Science 1986; 232: 1240-1242.
25. Yu C, Yang TH, Yeh CJ, Chuang LC. Combined use of NMR, distance geometry, and restrained energy minimization for the conformational analysis of 8-lysine-the vasopressin. Can. J. Chem. 1992; 70: 1950-1955.
26. 1H-NMR spectroscopy and molecular mechanics calculations. Int. J. Pept. Protein Res. 1991; 38: 528-538.
27. 8]-the vasopressin homologues. Magn. Reson. Chem. 1991; 29: 580-586.
28. 8] the vasopressin by two-dimensional NMR spectroscopy and theoretical conformation analysis. Bioorg. Khim. 1985; 11: 1180-1191.
29. 2 vasopressin agonists. J. Pept. Res. 2005; 66(Suppl. 1): 30-40.
30. Wu CK, Hu B, Rose JP, Liu ZJ, Nguyen TL, Zheng TL, Breslow E, Wang BC. Structures of an unliganded neurophysin and its the vasopressin complex: implications for binding and allosteric mechanisms. Protein Sci. 2001; 10: 1869-1880.
31. Ibrahim SB, Pattabhi V. Trypsin inhibition by a peptide hormone: crystal structure of trypsin-vasopressin complex. J. Mol. Biol. 2005; 348: 1191-1198.
32. Rodziewicz-Motowid3o S, Zhukov I, Kasprzykowski F, Grzonka Z, Ciarkowski J. Wójcik J. Conformational solution studies of (Sar(7))desamino- and (MeAla(7)) desamino-vasopressin analogues using NMR spectroscopy. J. Pept. Sci. 2002; 8: 347-364.
33. Bhaskaran R, Chuang LC, Yu C. Conformational properties of oxytocin in dimethyl sulfoxide solution - NMR and restrained molecular dynamics studies. Biopolymers 1992; 32: 1599-1608.
34. Wood SP, Tickle IJ, Treharne AM, Pitts JE, Mascarenhas Y. Li JY, Husain J, Cooper S, Blundell TL, Hruby VJ, Buku A, Fischman AJ, Wyssbrod HR. Crystal structure analysis of deamino-oxytocin: conformational flexibility and receptor binding. Science 1986; 232: 633-636.
35. Husain J, Nlundell TL, Cooper S, Pitts JE, Tickle IJ, Wood SP, Hruby VJ, Buku A, Fischman AJ, Wyssbrod HR, Mascerenhas Y. The conformation of deamino-oxytocin: X-ray analysis of the 'dry' and 'wet' forms. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 1990; 327: 625-654.
36. Mosberg HI, Hruby VJ, Meraldi JP. Conformational study of the potent peptide hormone antagonist [1-penicillamine,2-leucine]oxytocin in aqueous solution. Biochemistry 1981; 20: 2822-2828.
37. 7)-OT by NMR, Raman. CD spectroscopy and molecular modeling. J. Pept. Sci. 2005; 11: 365-378.
38. Shenderovich MD, Kövér KE, Wilke S, Collins N. Hruby VJ. Solution conformations of potent bicycle antagonists of oxytocin by nuclear magnetic resonance spectroscopy and molecular dynamic simulations. J. Am. Chem. Soc. 1997; 119: 5833-5846.
39. Tu AT, Lee J, Deb KK, Hruby VJ, Laser Raman spectroscopy and circular dichroism studies of the peptide hormones the mesotocin. vasotocin, lysine the vasopressin, and arginine the vasopressin. J. Biol. Chem. 1979; 254: 3272-3278.
40. Bax A, Freeman R. Enhanced NMR resolution by restricting the effective sample volume. J. Magn. Reson. 1985; 65: 355-360.
41. Kumar A, Ernst RR, Wüthrich K. A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross relaxation networks in biological macromolecules. Biochem. Biophys. Res. Commun. 1980; 95: 1-10.
42. Bothner-By AA, Stephens RL, Lee JM, Warren CD, Jeanloz RW. Structure determination of a tetrasaccharide: Transient nuclear Overhauser effects in the rotating frame. J. Am. Chem. Soc. 1980; 106: 811-813.
43. Bax A, Davis DG. Practical aspects of two-dimensional transverse NOE spectroscopy. J. Magn. Reson. 1985; 63: 207-213.
44. Kay LE, Keifer P, Saarinen T. Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity. J. Am. Chem. Soc. 1992; 114: 10663-10665.
45. Kontaxis G, Stonehouse J, Laue ED, Reeler J. The sensitivity of experiments which use gradient pulses for coherence-pathway selection. J. Magn. Reson., Ser. A 1994; 111: 70-76.
46. Bax A, Summers MF. Proton and carbon 13 assignments from sensitivity-enhanced detection of heteronuclear multiple-bond connectivity by 2D multiple quantum NMR. J. Am. Chem. Soc. 1986; 108: 2093-2094.
47. Koźmiński W. The new active-coupling-pattern tilting experiment for an efficient and accurate determination of homonuclear coupling constants. J. Magn. Reson. 1998; 134: 189-193.
48. 1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 1983; 117: 479-485.
49. Gottlieb HE, Kotlyar V, Nudelman A. NMR chemical shifts of common laboratory solvents as trace impurities. J. Org. Chem. 1997; 62: 7512-7515.
50. 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects. J. Biomol. NMR 1995; 5: 67-81.
51. Delaglio F, Grzesiek S, Geerten WV, Zhu G, Pfeifer J, Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 1995; 6: 277-293.
52. Varian, Nuclear Magnetic resonance Instruments, VnmrTM Software, Revision 5.3B 1/97.
53. Bartles C, Xia T, Billeter M, Günter P, Wütrich K. The program XEASY for the computer-supported NMR spectral analysis of biological macromolecules. J. Biomol. NMR 1995; 5: 1-10.
54. Case DA, Darden TA, Cheatham TE III, Simmerling CL, Wang J, Duke RE, Luo R, Merz KM, Wang B, Pearlman DA, Crowley M, Brozell S, Tsui V, Gohlke H, Mongan J, Hornak V, Cui G, Beroza P, Schafmeister C, Caldwell JW, Ross WS, Kollman PA. AMBER 8. University of California: San Francisco, 2004.
55. Güntert P, Mumenthaler C, Wüthrich K. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J. Mol. Biol. 1997; 273: 283-298.
56. Bolton PH, Carlson RMK, Croasmun WR, Crouch RC, Dabrowski J, Dyson HJ, Goljer I, Gray GA, Griesinger C, Hull WH, Kalbitzer HR, Kessler H, Martin GE, Rinaldi PL, Sattler M. Schleucher J, Schwalbe H, Seip S, Wright PE. In Two-Dimensional NMR Spectroscopy: Applications for Chemists and Biochemists, Croasmun WR, Carlson RMK (eds.). VCH: New York, 1994.
57. Pardi A, Billeter M, Wüthrich K. Calibration of the angular-dependence of the amide proton-C-alpha proton coupling-constants, 3JHN alpha, in a globular protein. Use of 3JHN alpha for identification of helical secondary structure, J. Mol. Biol. 1984; 180: 741-751.
58. Sanchez-Ferrer A, Nunez-Delicado E, Bru R. Software for viewing biomolecules in three dimensions on the Internet. Trends Biochem. Sci. 1995; 20: 286-288.
59. Koradi R, Billeter M, Wüthrich K. MOLMOL: a program for display and analysis of macromolecular structures, J. Mol. Graphics 1996; 14: 52-55.
60. 6-proline peptide bond of oxytocin, arginine the vasopressin, and lysine the vasopressin. J. Am. Chem. Soc. 1992; 114: 7331-7337.
61. Czaplewski C, Kaźmierkiewicz R, Ciarkowski J. Molecular modeling of the human the vasopressin V2 receptor/agonist complex. J. Comput. Aided Mol. Des. 1998; 12: 275-287.
62. Rose JP, Wu CK, Hsiao CD, Breslow E, Wang BC. Crystal structure of the neurophysin-oxytocin complex. Nat. Struct. Diol. 1996; 3: 163-169.
63. Ślusarz MJ, Giełdoń A, Ślusarz R, Ciarkowski J. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors - molecular dynamics study of the activated receptor-vasopressin-Gα systems. J. Pept. Sci. 2006; 12: 180-189.